JAZZ FY 2016 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.5B+12.3% YoY

Gross Profit

$1.4B92.9% margin

Operating Income

$592M39.8% margin

Net Income

$397M26.7% margin

EPS (Diluted)

$6.41

Cash Flow

Operating Cash Flow

$591M

Free Cash Flow

$409M

Stock-Based Comp.

$99M

Balance Sheet

Total Assets

$4.8B

Total Liabilities

$2.9B

Stockholders' Equity

$1.9B

Cash & Equivalents

$366M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.3B	+12.3%
Gross Profit	$1.4B	$1.2B	+13.1%
Operating Income	$592M	$508M	+16.4%
Net Income	$397M	$330M	+20.4%